These studies have demonstrated that supplementation of the endogenous CD4+CD25+ Treg cell population provides resistance to the disease, whereas depletion of Treg cells accelerates T1D progression, showing that CD4+Foxp3+ Treg cells are critical in the control of T1D in mouse models. This evidence concerns the gene CD4 and type 1 diabetes mellitus.